RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
        • 등재정보
        • 학술지명
        • 주제분류
        • 발행연도
        • 작성언어
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재후보

        Memantine Reverses Social Withdrawal Induced by Ketamine in Rats

        Ezequiel Uribe,José Landaeta,Richard Wix,Antonio Eblen 한국뇌신경과학회 2013 Experimental Neurobiology Vol.22 No.1

        The objective of this study was to determine the effect of memantine on schizophrenia-like symptoms in a ketamine-induced social withdrawal model in rats. We examined therapeutic effects of memantine, an NMDA antagonist, and haloperidol, a classic antipsychotic drug, on this behavioral model. Administration of memantine (10 or 15 mgㆍkg-1) significantly reduced ketamine-induced social withdrawal, and this effect was more effective than that of haloperidol (0.25 mgㆍkg-1) by restoring the social interaction between rats with no modification in general motor activity. These results suggest that memantine could have a therapeutic potential for schizophrenia.

      • KCI등재

        Neonatal Administration of Memantine Enhances Social Cognition in Adult Rats Subjected to Early Maternal Deprivation

        Eduardo Sánchez-Mendoza,Nayadoleni Nieves,Gustavo Merchor,Ezequiel Uribe 한국뇌신경과학회 2016 Experimental Neurobiology Vol.25 No.6

        Schizophrenia is considered a neurodevelopmental disorder; however, all the available treatment options are used when the disease becomes clinically significant in adolescence or early adulthood. Using a developmental rat model of schizophrenia, we examined whether neonatal treatment with memantine, an NMDA receptor modulator, can improve schizophrenic-like symptoms in adulthood. Early maternal deprivation in rats produces deficits in social interaction behaviors in adulthood. In contrast, memantine administrated in neonatal rats subjected to early maternal deprivation significantly reduces deficits in social interaction behaviors in adulthood. These results raise the possibility that pharmacological treatment with memantine at the early developmental stage helps people with a risk to develop schizophrenic-like symptoms.

      • KCI등재

        Drug Treated Schizophrenia, Schizoaffective and Bipolar Disorder Patients Evaluated by qEEG Absolute Spectral Power and Mean Frequency Analysis

        Richard Wix-Ramos,Antonio Eblen-Zajjur,Xiomara Moreno,Eduardo Capote,Gilbert González,Ezequiel Uribe 대한정신약물학회 2014 CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE Vol.12 No.1

        Objective: Research of electroencephalograph (EEG) power spectrum and mean frequency has shown inconsistent results inpatients with schizophrenic, schizoaffective and bipolar disorders during medication when compared to normal subjects thus;the characterization of these parameters is an important task. Methods: We applied quantitative EEG (qEEG) to investigate 38 control, 15 schizophrenic, 7 schizoaffective and 11 bipolar disordersubjects which remained under the administration of psychotropic drugs (except control group). Absolute spectral power (ASP),mean frequency and hemispheric electrical asymmetry were measured by 19 derivation qEEG. Group mean values were comparedwith non parametrical Mann-Whithney test and spectral EEG maps with z-score method at p<0.05. Results: Most frequent drug treatments for schizophrenic patients were neuroleptic+antiepileptic (40% of cases) or 2 neuroleptics(33.3%). Schizoaffective patients received neuroleptic+benzodiazepine (71.4%) and for bipolar disorder patients neuroleptic+antiepileptic (81.8%). Schizophrenic (at all derivations except for Fp1, Fp2, F8 and T6) and schizoaffective (only at C3)show higher values of ASP (+57.7% and +86.1% respectively) compared to control group. ASP of bipolar disorder patients didnot show differences against control group. The mean frequency was higher at Fp1 (+14.2%) and Fp2 (+17.4%) in bipolar disorderpatients than control group, but no differences were found in frequencies between schizophrenic or schizoaffective patientsagainst the control group. Majority of spectral differences were found at the left hemisphere in schizophrenic and schizoaffectivebut not in bipolar disorder subjects. Conclusion: The present report contributes to characterize quantitatively the qEEG in drug treated schizophrenic, schizoaffectiveor bipolar disorder patients.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼